Published in CMAJ on April 15, 1991
Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res (2003) 1.42
Trends in five-year survival of patients discharged after acute myocardial infarction. Can J Cardiol (2006) 0.84
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87
Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol (1967) 6.74
Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA (1988) 4.46
Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med (1979) 4.04
Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62
Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis (1969) 3.15
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med (1988) 2.98
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Psychosocial influences on mortality after myocardial infarction. N Engl J Med (1984) 2.72
Psychological hazards of convalescence following myocardial inarction. JAMA (1971) 2.57
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J (1983) 2.55
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med (1989) 2.28
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation (1979) 2.11
Prognosis and management after a first myocardial infarction. N Engl J Med (1990) 1.76
Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation (1989) 1.75
Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program. Psychosom Med (1989) 1.63
Efficacy of cardiac rehabilitation services. With emphasis on patients after myocardial infarction. Ann Intern Med (1988) 1.63
Influence of cigarette smoking on morbidity and mortality after myocardial infarction. Br Heart J (1983) 1.62
Pericarditis after acute myocardial infarction. Br Med J (1971) 1.39
Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med (1986) 1.29
Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol (1984) 1.29
Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med (1984) 1.24
Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. JAMA (1989) 1.20
Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. J Am Coll Cardiol (1987) 1.20
Exercise training soon after myocardial infarction. Am J Cardiol (1979) 1.17
Digitalis-associated cardiac mortality after myocardial infarction. Circulation (1981) 1.04
Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation (1979) 1.03
The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. Circulation (1986) 0.97
Relation of exercise to the recurrence rate of myocardial infarction in men. Ontario Exercise-Heart Collaborative Study. Am J Cardiol (1983) 0.96
Risk factor modification after myocardial infarction. Ann Intern Med (1988) 0.92
Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med (1985) 0.92
Early return to work after uncomplicated myocardial infarction. Results of a randomized trial. JAMA (1988) 0.92
Psychosocial and physiological predictors of sudden cardiac death after healing of acute myocardial infarction. Am J Cardiol (1988) 0.88
Specialized testing after recent acute myocardial infarction. Ann Intern Med (1989) 0.87
Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol (1980) 0.86
The cost-effectiveness of routine post myocardial infarction exercise stress testing. Can J Cardiol (1990) 0.85
Comparison of clinical and treadmill variables for the prediction of outcome after myocardial infarction. J Am Coll Cardiol (1984) 0.85
Role of calcium antagonists in systemic hypertension. Am J Cardiol (1987) 0.81
One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol (1989) 0.81
Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation (1989) 0.81
Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol (1986) 0.79
Return to work after a myocardial infarction: the influence of background factors, work characteristics and illness severity. Scand J Soc Med (1986) 0.77
Can atherosclerotic lesions regress? Angiographic evidence in humans. Am J Cardiol (1990) 0.76
Isolation of an E. coli strain with a mutation affecting DNA polymerase. Nature (1969) 12.96
Mutation selection and the natural history of cancer. Nature (1975) 9.73
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet (2001) 6.86
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
A new pathway for DNA repair in Escherichia coli. Nature (1977) 5.37
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
A randomized trial of psychosocial support during high-risk pregnancies. The Latin American Network for Perinatal and Reproductive Research. N Engl J Med (1992) 3.81
Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2001) 3.46
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
The origin of human cancers. Nature (1981) 3.24
Inappropriate reattendances in out-patient departments. J Public Health Med (1992) 3.14
The segregation of DNA in epithelial stem cells. Cell (1978) 3.12
Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med (1980) 3.12
Mechanisms of directed mutation. Genetics (1992) 2.92
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med (1979) 2.91
Health services research for decision-makers: the use of the Delphi technique to determine health priorities. J Health Polit Policy Law (1977) 2.79
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67
Mapping the prion protein using recombinant antibodies. J Virol (1998) 2.64
The developing role of ecotoxicology in industrial ecology and natural capitalism. Environ Health Perspect (2000) 2.60
Enhancer-like interferon responsive sequences of the human and murine (2'-5') oligoadenylate synthetase gene promoters. EMBO J (1988) 2.53
How do researchers influence decision-makers? Case studies of Mexican policies. Health Policy Plan (1999) 2.52
Doctors' perceptions of pressure from patients for referral. BMJ (1991) 2.35
The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (2007) 2.27
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest (1990) 2.14
Depression and 1-year prognosis in unstable angina. Arch Intern Med (2000) 2.13
New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ (2001) 2.12
How should results from completed studies influence ongoing clinical trials? The CAFA Study experience. Ann Intern Med (1991) 2.06
Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. Circulation (1992) 1.97
Angina pectoris with normal coronary arteries. Transvenous myocardial biopsy in diagnosis. Lancet (1974) 1.97
"Alone, I wouldn't have known what to do": a qualitative study on social support during labor and delivery in Mexico. Soc Sci Med (1998) 1.92
Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell (1999) 1.87
Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med (1997) 1.86
Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis (1983) 1.83
Climate change and the integrity of science. Science (2010) 1.80
Quantitation of the adaptive response to alkylating agents. Nature (1979) 1.80
Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med (2000) 1.80
Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum (1994) 1.68
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess (2013) 1.66
The costs of prevention. BMJ (1995) 1.66
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer (1992) 1.62
Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene. Mol Cell Biol (1987) 1.59
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature (1984) 1.54
Random components in mutagenesis. Nature (1982) 1.53
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer (1990) 1.52
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J (1996) 1.52
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
Directed mutation. Science (1993) 1.51
The inducible repair of alkylated DNA. Prog Nucleic Acid Res Mol Biol (1981) 1.51
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J (2002) 1.50
Measuring health outcomes. BMJ (1996) 1.49
Depression in patients with cardiac disease: a practical review. J Psychosom Res (2000) 1.47
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
Effect of 32P decay upon DNA synthesis by a radiation-sensitive strain of Escherichia coli. J Mol Biol (1966) 1.46
A study on maternal mortality in Mexico through a qualitative approach. J Womens Health Gend Based Med (2000) 1.46
The cancer problem. Sci Am (1975) 1.46
Reducing bedrest following arterial puncture for coronary interventional procedures--impact on vascular complications: the BAC Trial. J Invasive Cardiol (2001) 1.45
Pathways of mutagenesis and repair in Escherichia coli exposed to low levels of simple alkylating agents. J Bacteriol (1978) 1.43
The effects of alternate exposure to altitude and sea level on world-class middle-distance runners. Med Sci Sports (1970) 1.42
Autoradiography of HeLa cell DNA. J Mol Biol (1966) 1.41
Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs. Can J Cardiol (2005) 1.41
The power of information and contraceptive choice in a family planning setting in Mexico. Sex Transm Infect (2000) 1.40
Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med (1999) 1.40
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction. Can J Cardiol (1996) 1.39
Acute reduction of lipoprotein(a) by tissue-type plasminogen activator. Circulation (1992) 1.39
Variations in measured vessel diameters using coronary measurement system. Cathet Cardiovasc Diagn (1996) 1.39
Establishing patient preferences for blood transfusion support: an application of conjoint analysis. J Health Serv Res Policy (1998) 1.38
Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. Ann Intern Med (1990) 1.38
Did HIV and HTLV originate in Africa? JAMA (1990) 1.38
A review of open tibia fractures in children. J Pediatr Orthop (1995) 1.35
Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices. BJOG (2006) 1.35
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess (2007) 1.34
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc Natl Acad Sci U S A (1996) 1.33
Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop Relat Res (1992) 1.33
Quality of life after myocardial infarction. J Clin Epidemiol (1994) 1.31
Ilio-psoas bursa. Br J Radiol (1972) 1.30
Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2000) 1.28
The etiology of maternal mortality in developing countries: what do verbal autopsies tell us? Bull World Health Organ (2001) 1.27
Effect of cyanide and carbon monoxide on the replication of bacterial DNA in vivo. J Mol Biol (1968) 1.26
Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci U S A (1995) 1.25
The occurrence of heritable Mu excisions in starving cells of Escherichia coli. EMBO J (1994) 1.20
Genetically Engineered Erwinia carotovora: Survival, Intraspecific Competition, and Effects upon Selected Bacterial Genera. Appl Environ Microbiol (1990) 1.20
Magnetic resonance imaging of anal fistulae. Lancet (1992) 1.17
Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med (2001) 1.16
Macular-foveal capillaries in human retina. Aust J Ophthalmol (1973) 1.16
Patient weighting of importance of asthma symptoms. Thorax (2001) 1.16
Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J Biol Chem (1993) 1.16
Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med (1999) 1.14
Genetically Engineered Erwinia carotovora in Aquatic Microcosms: Survival and Effects on Functional Groups of Indigenous Bacteria. Appl Environ Microbiol (1989) 1.13
Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med (1999) 1.12
The clinical outcome of needle aspirations of the lung when cancer is not diagnosed. Ann Thorac Surg (1986) 1.12
Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. J Clin Oncol (1996) 1.12
Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins (2001) 1.11
Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery (1991) 1.10
Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: a study incorporating epidemiological and food source traceback results. Epidemiol Infect (2010) 1.10
Incomplete relaxation between beats after myocardial hypoxia and ischemia. J Clin Invest (1974) 1.09
Development of clinical guidelines in a health district: an attempt to find consensus. Qual Health Care (1992) 1.09